| Alterations of the brain reward system in antipsychotic naïve schizophrenia patients MØ Nielsen, E Rostrup, S Wulff, N Bak, H Lublin, S Kapur, B Glenthøj Biological psychiatry 71 (10), 898-905, 2012 | 242 | 2012 |
| EPA guidance on assessment of negative symptoms in schizophrenia S Galderisi, A Mucci, S Dollfus, M Nordentoft, P Falkai, S Kaiser, ... European Psychiatry 64 (1), e23, 2021 | 208 | 2021 |
| Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia MO Nielsen, E Rostrup, S Wulff, N Bak, BV Broberg, H Lublin, S Kapur, ... Archives of general psychiatry 69 (12), 1195-1204, 2012 | 172 | 2012 |
| EPA guidance on treatment of negative symptoms in schizophrenia S Galderisi, S Kaiser, I Bitter, M Nordentoft, A Mucci, M Sabé, ... European psychiatry 64 (1), e21, 2021 | 148 | 2021 |
| Striatal reward activity and antipsychotic-associated weight change in patients with schizophrenia undergoing initial treatment MØ Nielsen, E Rostrup, S Wulff, B Glenthøj, BH Ebdrup JAMA psychiatry 73 (2), 121-128, 2016 | 84 | 2016 |
| A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale A Mucci, A Vignapiano, I Bitter, SF Austin, C Delouche, S Dollfus, A Erfurth, ... European Neuropsychopharmacology 29 (8), 947-959, 2019 | 81 | 2019 |
| Associations between cognitive function and levels of glutamatergic metabolites and gamma-aminobutyric acid in antipsychotic-naïve patients with schizophrenia or psychosis KB Bojesen, BV Broberg, B Fagerlund, K Jessen, MB Thomas, A Sigvard, ... Biological psychiatry 89 (3), 278-287, 2021 | 57 | 2021 |
| Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade BH Ebdrup, JM Raghava, MØ Nielsen, E Rostrup, B Glenthøj Journal of Psychiatry and Neuroscience 41 (2), 133-141, 2016 | 56 | 2016 |
| Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology N Bak, BH Ebdrup, B Oranje, B Fagerlund, MH Jensen, SW Düring, ... Translational psychiatry 7 (4), e1087-e1087, 2017 | 50 | 2017 |
| Striatal D2/3 Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome S Wulff, LH Pinborg, C Svarer, LT Jensen, MØ Nielsen, P Allerup, N Bak, ... Schizophrenia Bulletin 41 (5), 1143-1152, 2015 | 50 | 2015 |
| A machine-learning framework for robust and reliable prediction of short-and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on … KS Ambrosen, MW Skjerbæk, J Foldager, MC Axelsen, N Bak, ... Translational psychiatry 10 (1), 276, 2020 | 44 | 2020 |
| Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients BH Ebdrup, MC Axelsen, N Bak, B Fagerlund, B Oranje, JM Raghava, ... Psychological medicine 49 (16), 2754-2763, 2019 | 34 | 2019 |
| Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients D Nordholm, E Rostrup, V Mondelli, L Randers, MØ Nielsen, S Wulff, ... Psychoneuroendocrinology 92, 72-80, 2018 | 31 | 2018 |
| The relation between dopamine D2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients S Wulff, MØ Nielsen, E Rostrup, C Svarer, LT Jensen, L Pinborg, ... Psychological Medicine 50 (2), 220-228, 2020 | 28 | 2020 |
| Patterns of cortical structures and cognition in antipsychotic-naïve patients with first-episode schizophrenia: a partial least squares correlation analysis K Jessen, RCW Mandl, B Fagerlund, KB Bojesen, JM Raghava, HG Obaid, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 4 (5), 444-453, 2019 | 28 | 2019 |
| Alterations of intrinsic connectivity networks in antipsychotic-naïve first-episode schizophrenia S Anhøj, M Ødegaard Nielsen, MH Jensen, K Ford, B Fagerlund, ... Schizophrenia Bulletin 44 (6), 1332-1340, 2018 | 27 | 2018 |
| Short-term safety of preoperative administration of botulinum toxin A for the treatment of large ventral hernia with loss of domain MØ Nielsen, J Bjerg, A Dorfelt, LN Jørgensen, KK Jensen Hernia 24, 295-299, 2020 | 26 | 2020 |
| Negative symptoms and reward disturbances in schizophrenia before and after antipsychotic monotherapy MØ Nielsen, E Rostrup, BV Broberg, S Wulff, B Glenthøj Clinical EEG and neuroscience 49 (1), 36-45, 2018 | 26 | 2018 |
| European validation of the self-evaluation of negative symptoms (SNS): a large multinational and multicenter study S Dollfus, A Mucci, GM Giordano, I Bitter, SF Austin, C Delouche, A Erfurth, ... Frontiers in psychiatry 13, 826465, 2022 | 25 | 2022 |
| Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients HG Andersen, JM Raghava, C Svarer, S Wulff, LB Johansen, ... Frontiers in Neuroscience 14, 484, 2020 | 23 | 2020 |